# Comparison of the Effects of Standardized Chokeberry Extracts With Various Formulations on the Levels of Selected Markers Associated With Cardiovascular Disease

> **NCT05988099** · NA · COMPLETED · sponsor: **AronPharma Sp. z o. o.** · enrollment: 40 (actual)

## Conditions studied

- Hypertension
- Hypercholesterolemia

## Interventions

- **DIETARY_SUPPLEMENT:** Complex product
- **DIETARY_SUPPLEMENT:** Chokeberry extract in liposomal formulation
- **DIETARY_SUPPLEMENT:** Chokeberry extract in traditional formulation
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05988099
- **Lead sponsor:** AronPharma Sp. z o. o.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-20
- **Primary completion:** 2023-07-28
- **Final completion:** 2023-07-28
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2023-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05988099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05988099, "Comparison of the Effects of Standardized Chokeberry Extracts With Various Formulations on the Levels of Selected Markers Associated With Cardiovascular Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05988099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*